Endoglin (CD105) positive microvessel density and its relationship with lymph node metastasis in squamous cell carcinoma of the tongue

Archives of Iranian Medicine

Volumn 14, Issue 4, 2011, Pages 276-280

  Eshghyar, Nosratolah ^a   Mohammadi, Navid ^b   Rahrotaban, Sedigheh ^c   Motahhary, Pouria ^a   Mohammad Ali Vahedi Vaez, S ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d PRIVATE PRACTICE   (Iran)

Author keywords

Carcinoma; Endoglin protein; Neovascularization; Pathologic; Squamous cell

Indexed keywords

ENDOGLIN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CAPILLARY DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METASTASIS POTENTIAL; PREDICTIVE VALUE; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TONGUE CARCINOMA; TUMOR INVASION; METASTASIS; MICROVASCULATURE; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); NONPARAMETRIC TEST; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TONGUE; TONGUE TUMOR; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TONGUE; TONGUE NEOPLASMS; YOUNG ADULT;

EID: 84873039683     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Martone T, Rosso P, Albera R, Migliaretti G, Fraire F, Pignataro L, et al. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome. Oral Oncol. 2005; 41: 147-55.
2. Schimming R, Marme D. Endoglin (CD105) expression in squamous cell carcinoma of the oral cavity. Head Neck. 2002; 24: 151-156.
3. Taskiran C, Erdem O, Onan A, Arisoy O, Acar A, Vural C, et al. The prognostic value of endoglin (CD105) expression in ovarian carcinoma. Int J Gynecol Cancer. 2006; 16: 1789-1793.
4. Kumar S, Hellal A, Li C, Byrne G, Haboubi N, Wang JM, et al. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res. 1999; 59: 856-861.
5. Saad RS, Jasnosz KM, Tung MY, Silverman JF. Endoglin (CD105) expression in endometrial carcinoma. Int J Gynecol Pathol. 2003; 22: 248-253.
6. Chien CY, Su CY, Hwang CF, Chuang HC, Hsiao YC, Wu SL, et al. Clinicopathologic significance of CD105 expression in squamous cell carcinoma of the hypopharynx. Head Neck. 2006; 28: 441-446.
7. Zatterstrom UK, Brun E, Willen R, Kjellén E, Wennerberg J. Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck. 1995; 17: 312-318.
8. Srivastava A, Laidler P, Davies R, Horgan K, Hughes LE. The prognostic signi_cance of tumor vascularity in intermediate-thickness (0.76 - 4.0 mm thick) skin melanoma. A quantitative histological study. Am J Pathol. 1988; 133: 419-423.
9. Macchiarini P, Fontani G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularization to metastasis of nonsmall cell lung cancer. Lancet. 1992; 340: 145-146.
10. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 1991; 324: 1-8.
11. Dickinson AJ, Fox SB, Persad RA, Hollyer J, Sibley GN, Harris AL. Quanti_cation of angiogenesis as an independent predictor of prognosis in invasive bladder carcinoma. Br J Urol. 1994; 74: 762-766.
12. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 1993; 143: 401-409.
13. Wiggins DL, Granai CO, Steinhoff MM, Calabresi P. Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol. 1995; 56: 353-356.
14. Obermair A, Kohlberger P, Bancher-Todesca D, Tempfer C, Sliutz G, Leodolter S, et al. In_uence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol Oncol. 1996; 63: 204-209.
15. Abula-a O, Triest WE, Sherer DM. Angiogenesis in primary and metastatic epithelial ovarian carcinoma. Am J Obstet Gynecol. 1997; 177: 541-547.
16. Abula-a O, Triest WE, Sherer DM, Hansen CC, Ghezzi F. Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma. Obstet Gynecol. 1995; 86: 479-485.
17. Duff SE, Li C, Garland JM, Kumar S. CD105 is important for angiogenesis: Evidence and potential applications. FASEB J. 2003; 17: 984-992.
18. Chuang HC, Su CY, Huang HY, Chien CY, Chen CM, Huang CC. High expression of CD105 as a prognostic predictor of early tongue cancer. Laryngoscope. 2006; 116: 1175-1179.
19. Martone T, Rosso P, Albera R, Migliaretti G, Fraire F, Pignataro L, et al. Prognostic relevance of CD105 microvessel density in HNSCC patient outcome. Oral Oncol. 2005; 41: 147-155.
20. Yagasaki H, Kawata N, Takimoto Y, Nemoto N. Histopathological analysis of angiogenic factors in renal cell carcinoma. Int J Urol. 2003; 10: 220-227.
21. Dales JP, Garcia S, Bonnier P, Andrac-Meyer L, Ramuz O, Carpentier- Meunier S, et al. CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas: correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients. Am J Clin Pathol. 2003; 119: 374-380.
22. Bryen M, Koppang HS, Lilleng R, Stene T, Bang G, Dabelsteen E. New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinoma. J Oral Pathol Med. 1989; 18: 432-473.
23. Van Hoef ME, Knox WF, Dhesi SS, Howell A, Schor AM. Assessment of tumor vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer. 1993; 29A: 1141-1145.
24. Nagatsuka H, Hibi K, Gunduz M, Tsujigiwa H, Tamamura R, Sugahara T, et al. Various immunostaining patterns of CD31, CD34, and endoglin and their relationship with lymph node metastasis in oral squamous cell carcinoma. J Oral Pathol Med. 2005; 34: 70-76.
25. Zeng Y, Opeskin K, Horvath LG, Sutherland RL, Williams ED. Lymphatic vessel density and lymph node metastasis in prostate cancer. The Prostate. 2005; 65: 222-230.
26. Sharma S, Sharma MC, Sarkar C. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology. 2005; 46: 481-489.
27. Kirschner CV, Alanis-Amezcua JM, Martin VG, Luna N, Morgan E, Yang JJ, et al. Angiogenesis factor in endometrial carcinoma: a new prognostic indicator? Am J Obstet Gynecol. 1996; 174: 1879-1884.
28. Giatromanolaki A, Sivridis E, Koukourakis MI, Georgoulias V, Gatter KC, Harris AL. Intratumoral angiogenesis: A new prognostic indicator for stage I endometrial adenocarcinoma? Oncol Res. 1999; 11: 205-212.
29. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, et al. Quantification of angiogenesis in solid human tumors: an international consensus on the methodology and criteria of evaluation. Eur J Cancer. 1996; 32A: 2474-2484.
30. Fox SB, Gatter KC, Harris A. Tumor angiogenesis. J Pathol. 1996; 179: 232-237.
31. Page D, Jensen R. Angiogenesis in human breast carcinoma: what is the question? Hum Pathol. 1995; 26: 1173-1174.
32. Lindmark G, Gerdin B, Sundberg C, Paplan L, Bergstrom R, Gimelius B. Prognostic signi_cance of the microvascular count in colorectal cancer. J Clin Oncol. 1996; 14: 461-466.
33. Kaku T, Kamura T, Kinukawa N, Kobayashi H, Sakai K, Tsuruchi N, et al. Angiogenesis in endometrial carcinoma. Cancer. 1997; 80: 741-747.
34. Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, Delia D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood. 1990; 75: 2417-2426.
35. Mietinnen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34, BNH9 antibody to H- and Y-antigens: evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol. 1994; 7: 82-90.
36. Kuzu I, Bicknell R, Harris AL, Jones M, Gatter KC, Mason DY. Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumors. J Clin Pathol. 1992; 45: 143-148.
37. Lindenmayer AE, Miettinen M. Immunophenotypic features of uterine stromal cells. CD34 expression in endocervical stroma. Virchows Arch. 1995; 426: 457-460.
38. Brewer CA, Setterdahl JJ, Li MJ, Johnston JM, Mann JL, McAsey ME. Endoglin expression as a measure of microvessels density in cervical cancer. Obstet Gynecol. 2000; 96: 224-228.39.
39. Wang JM, Kumar S, Pye D, Haboubi N, al-Nakib L. Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers. J Natl Cancer Inst. 1994; 86: 386-388.
40. Bodey B, Bodey B Jr, Siegel SE, Kaiser HE. Over-expression of endoglin (CD 105): a marker of breast carcinoma-induced neovascularization. Anticancer Res. 1998; 18: 3621-3628.
41. Tumuluri V, Thomas GA, Fraser IS. The relationship of proliferating cell density at the invasive tumour front with prognostic and risk factors in human oral squamous cell carcinoma. J Oral Pathol Med. 2004; 33: 204-208.
42. Odell EW, Jani P, Sherriff M, Ahluwalia SM, Hibbert J, Levison DA, et al. The prognostic value of individual histologic grading parameters in small lingual squamous cell carcinomas. The importance of the pattern of invasion. Cancer. 1994; 74: 789-794.
43. Bryne M. Is the invasive front of an oral carcinoma the most important area for prognostication? Oral Dis. 1998; 4: 70-77.